share_log
Reuters ·  May 2 08:04
Neurocrine Biosciences : Oppenheimer Raises Target Price to $216 From $200
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment